GLP-1 drugs: what DC Medicaid paid

Q: Does a paid prescription mean DC Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

DC Medicaid shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read DC Medicaid's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What DC Medicaid’s payment record shows

In 2026Q1, the product DC Medicaid paid for most often was Ozempic®, at 3,954 prescriptions¹⁹ of the 6,490 to 6,787^{1,7,13,19,25,43} across all 8 products, or 61 percent of the published count.

DC Medicaid itself reimbursed at least $6,071,971 for these products in the quarter, about $940 per prescription. Pharmacies were paid $6,265,555 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Mounjaro®, at about $998.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what DC Medicaid finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, DC Medicaid. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What DC Medicaid paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what DC Medicaid paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Managed care	at least 193¹	3%	$180,876	$191,649	$937
tirzepatideMounjaro®	Both1,795 managed care, 110 direct	at least 1,905⁷	30%	$1,900,759	$1,982,392	$998
semaglutideWegovy®	Managed care	at least 113¹³	2%	$92,274	$125,679	$817
semaglutideOzempic®	Both3,551 managed care, 403 direct	at least 3,954¹⁹	61%	$3,795,204	$3,860,202	$960
semaglutideRybelsus®	Managed care	at least 31²⁵	<1%	$28,447	$31,221	$918
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Fee-for-service	at least 261⁴³	4%	$74,411	$74,411	$285

DC Medicaid publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 28.9 to 30.2 prescriptions per thousand people enrolled in DC Medicaid, on an average of 224,478 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 27 of the 168 product-quarters it holds a row for here, which is 16 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether DC Medicaid pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what DC Medicaid paid for each product, quarter by quarter

Prescriptions DC Medicaid paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld6 of 6 product codes withheld	at least 26 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$6,641 paid	at least 80 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$35,882 paid	at least 107 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$71,518 paid	145 paid prescriptions in the quarter (2025Q4)²Count$126,807 paid	at least 193 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$180,876 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	at least 24 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$16,792 paid	at least 14 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$10,563 paid	at least 88 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$66,575 paid	at least 172 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$129,242 paid	at least 302 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$244,128 paid	at least 516 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$360,491 paid	at least 811 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$498,645 paid	at least 1,005 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$605,667 paid	at least 1,227 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$773,693 paid	at least 1,431 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$923,618 paid	at least 1,279 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$1,004,093 paid	at least 1,404 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$1,281,803 paid	at least 1,567 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$1,545,320 paid	at least 1,905 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$1,900,759 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable¹⁵Withheld4 of 4 product codes withheld	at least 17 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$10,841 paid	at least 26 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$18,040 paid	at least 58 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$41,513 paid	at least 54 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$43,628 paid	at least 41 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$26,857 paid	at least 27 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$18,696 paid	at least 113 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$92,274 paid
semaglutideOzempic®	at least 656 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$549,179 paid	at least 735 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$617,106 paid	at least 789 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$661,346 paid	at least 1,035 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$884,001 paid	at least 1,034 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$804,437 paid	at least 1,332 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$998,427 paid	at least 1,284 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,036,256 paid	at least 1,330 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$1,110,828 paid	at least 1,911 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$1,587,327 paid	at least 2,365 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$1,967,312 paid	at least 2,374 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$2,002,854 paid	at least 2,141 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$1,827,710 paid	at least 3,196 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$2,513,590 paid	at least 4,427 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$3,206,511 paid	at least 4,672 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$3,383,597 paid	at least 4,926 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$3,540,433 paid	at least 4,921 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$3,481,730 paid	at least 4,076 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$3,173,373 paid	at least 3,639 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$3,194,684 paid	at least 3,350 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$3,160,757 paid	at least 3,954 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$3,795,204 paid
semaglutideRybelsus®	at least 11 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$8,755 paid	at least 12 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$8,012 paid	at least 16 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$11,996 paid	at least 31 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$27,234 paid	at least 44 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$19,659 paid	at least 60 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$27,918 paid	at least 62 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$32,110 paid	at least 73 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$50,175 paid	at least 73 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$50,638 paid	at least 105 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$67,846 paid	at least 71 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$60,710 paid	at least 87 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$59,135 paid	at least 118 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$65,689 paid	at least 176 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$63,445 paid	at least 165 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$54,318 paid	at least 138 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$40,468 paid	at least 146 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$45,525 paid	at least 88 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$30,675 paid	at least 54 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$26,180 paid	at least 15 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$14,422 paid	at least 31 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$28,447 paid
liraglutideSaxenda®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³¹Withheld1 of 1 product codes withheld
liraglutideVictoza®range 110 to 396	at least 394 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld⁴²At least$345,610 paid	396 paid prescriptions in the quarter (2021Q2)⁴²Count$362,006 paid	328 paid prescriptions in the quarter (2021Q3)⁴²Count$295,803 paid	312 paid prescriptions in the quarter (2021Q4)⁴²Count$279,256 paid	255 paid prescriptions in the quarter (2022Q1)⁴¹Count$207,868 paid	269 paid prescriptions in the quarter (2022Q2)⁴¹Count$206,086 paid	235 paid prescriptions in the quarter (2022Q3)⁴¹Count$181,187 paid	208 paid prescriptions in the quarter (2022Q4)⁴¹Count$179,595 paid	130 paid prescriptions in the quarter (2023Q1)⁴⁰Count$105,032 paid	110 paid prescriptions in the quarter (2023Q2)⁴⁰Count$83,450 paid	at least 59 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld⁴⁰At least$47,822 paid	at least 30 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$26,576 paid	at least 30 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³⁹At least$20,837 paid	at least 17 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$10,333 paid	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³⁹Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³⁹Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³⁸No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³⁸No row	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld1 of 1 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable⁴⁵Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable⁴⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable⁴⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter⁴⁴No row	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable⁴⁴Withheld2 of 2 product codes withheld	at least 261 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$74,411 paid

What this page cannot tell you

Whether DC Medicaid covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open District of Columbia in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, DC
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND 5", "suppression_used": "false", "number_of_prescriptions": "49"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, DC
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "50"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, DC
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND 1", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, DC
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like ZEPBOUND%, state DC, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, DC
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like ZEPBOUND%, state DC, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, DC
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like ZEPBOUND%, state DC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, DC
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "412"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, DC
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "387"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, DC
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "370"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, DC
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "105"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, DC
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, DC
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like MOUNJARO%, state DC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, DC
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "27"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, DC
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "23"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, DC
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, DC
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1.7", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, DC
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, DC
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like WEGOVY%, state DC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, DC
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2 ", "suppression_used": "false", "number_of_prescriptions": "1380"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, DC
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1775"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, DC
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1815"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, DC
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2023", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "919"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, DC
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "669"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, DC
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "548"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, DC
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "20"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, DC
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "60"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, DC
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "80"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, DC
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "38"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, DC
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "37"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, DC
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "20"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, DC
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, DC
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like SAXENDA%, state DC, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, DC
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like SAXENDA%, state DC, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, DC
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, DC
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, DC
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, DC
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 3-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, DC
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, DC
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, DC
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "70"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, DC
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "147"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, DC
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "231"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, DC
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state DC, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "DC", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "117"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, DC
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state DC, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, DC
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state DC, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, DC
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state DC, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like LIRAGLUTID%, state DC, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, DC
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state DC, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like LIRAGLUTID%, state DC, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, DC
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state DC, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "DC", "product_name": "product_name like LIRAGLUTID%, state DC, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 38 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 10 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean DC Medicaid covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.